Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), a leading cause of chronic liver disease, has increased worldwide along with the epidemics of obesity and related dysmetabolic conditions characterized by impaired glucose metabolism and insulin signaling, such as ty...

Полное описание

Библиографические подробности

Главные авторы:	Bruno Ramos-Molina, Joana Rossell, Alejandra Pérez-Montes de Oca, Eva Pardina, Idoia Genua, Marina I. Rojo-López, María Teresa Julián, Núria Alonso, Josep Julve, Didac Mauricio
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2024-06-01
Серии:	Frontiers in Endocrinology
Предметы:	steatotic liver hepatic fibrosis steatohepatitis sphingolipids inflammation lipotoxicity
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1400961/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!